Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane
2007
Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
16
Citations
NaN
KQI